Bob Trevino Likes It, the feature debut from writer-director Tracie Laymon, is a wonderfully moving portrait of friendship ...

Laura Coleman and Ronenn Roubenoff had been platonic friends, colleagues, and scientific peers, but when the opportunity for ...

It's no secret that many celebrities wear extensions to change their hair. Here's what they look like without those long extensions.

An interview with Terri Thal, who worked as Bob Dylan's first manager/booking agent in New York City in the early '60s.

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...

Eli Lilly plans four new U.S. manufacturing sites, expanding domestic production and reshoring pharmaceutical ingredient manufacturing. $50B expansion since 2020 includes four sites, creating over ...

Eli Lilly (LLY) announced Wednesday that it is ramping up US manufacturing, adding four new sites to help increase the production of key drug ingredients. Three of the four sites will produce ...

Michael Phelps' former coach, Bob Bowman, recently reacted to a throwback photo of the swimming legend shared on social media. The image captures a young Phelps sitting near the poolside during ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.

Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the newly introduced Zepbound Self Pay Journey Program. The company said ...

Compounding pharmacies that have been selling hundreds of thousands of doses of copies of Lilly's Zepbound and Novo's Wegovy while the medicines were in shortage are running out of time to produce ...